Pictet Asset Management (Switzerland)’s BioNTech BNTX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$19.9M	Sell	184,132 -67,200	-27%	-$7.56M	0.02%	466
2023 Q1	$31.3M	Buy	251,332 +142,306	+131%	+$19.5M	0.04%	370
2022 Q4	$16.4M	Sell	109,026 -476,099	-81%	-$73.3M	0.02%	488
2022 Q3	$78.9M	Sell	585,125 -40,964	-7%	-$6.26M	0.12%	217
2022 Q2	$93.3M	Buy	626,089 +97,247	+18%	+$14.9M	0.13%	205
2022 Q1	$90.2M	Buy	528,842 +271,059	+105%	+$45.5M	0.1%	233
2021 Q4	$66.5M	Buy	257,783 +186,891	+264%	+$51.2M	0.07%	298
2021 Q3	$19M	Buy	+70,892	New	+$22.5M	0.02%	528

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BNTX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its BioNTech (BNTX) stake by 27% in Q2 2023, selling an estimated $7.56M and leaving 184,132 shares worth $19.9M. The position accounts for 0.02% of the portfolio, ranked #466.

Pictet Asset Management (Switzerland) first reported a position in BNTX in Q3 2021 and has held it in 8 quarters since. The position peaked at $93.3M in Q2 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

Pictet Asset Management (Switzerland) held 184,132 shares of BioNTech worth $19.9M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 67,200 BioNTech shares in Q2 2023, an estimated $7.56M.
BioNTech made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #466 holding.
Pictet Asset Management (Switzerland) first reported a position in BioNTech in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s BioNTech position peaked at $93.3M in Q2 2022.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.